Skip to content
Screener

Other, net at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$50K+50.0%
Labcorp Holdings logo
Labcorp HoldingsLH
-$3.4M-3.0%

Other financials

Income statement

See full
Revenue$3.0B+10.2%
Gross profit$1.0B+8.9%
Operating income$459.0M+4.8%
Net income$320.0M+13.5%
EPS (diluted)$2.84+15.0%

Balance sheet

See full
Cash & equivalents$626.0M+96.2%
Total debt$6.4B0.0%
Total equity$7.5B+4.0%
Total assets$16.9B+6.1%

Cash flow

See full
Operating cash flow$597.0M+9.7%
CapEx$138.0M+27.8%
Free cash flow$459.0M+5.3%

Valuation

See full
Market cap$26.32B+36.1%
Enterprise value$32.08B+26.3%
P/E24.8×+4.4×
P/S2.3×+0.4×

Profitability

See full
Gross margin33.1%+0.1pp
Operating margin14.1%+0.1pp
Net margin9.2%+0.2pp
FCF margin11.7%0.0pp

Returns & leverage

See full
Return on equity14.4%+0.7pp
Debt / equity0.8×0.0×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001022079-26-000070
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Employee payroll tax withholdings on stock issued under stock-based compensation plans(38)(42)
Dividends paid(184)(174)
Distributions to noncontrolling interest partners(22)(29)
Other financing activities, net(109)(50)
Net cash used in financing activities(381)(854)
Effect of exchange rate changes on cash and cash equivalents and restricted cash(2)5
Net change in cash and cash equivalents and restricted cash206(230)
Cash and cash equivalents and restricted cash, beginning of period420549

Cover / Front Matter

FAQ

What is Quest Diagnostics's other, net?
Quest Diagnostics (DGX) reported other, net of -$25M in Q2 2026.
How has Quest Diagnostics's other, net changed year-over-year?
Quest Diagnostics's other, net decreased by 327.3% year-over-year, from $11M to -$25M.
What is the long-term trend for Quest Diagnostics's other, net?
Over 2 years (2022 to 2025), Quest Diagnostics's other, net has grown at a 0.0% compound annual growth rate (CAGR), from -$39M to $39M.
What does other, net mean?
Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.

Ask your AI about Quest Diagnostics's other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude